Edgewise Therapeutics Inc (EWTX)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
CEO:
Kevin Koch
Employees:
C/O ORBIMED ADVISORS LLC, 601 LEXINGTON AVE, 54TH FLR., NEW YORK, NY 10022
212-739-6451

Our vision is to improve the lives of patients and families suffering from rare muscle disorders by building the world’s leading muscle-focused, precision medicine company. At Edgewise, patients are at the core of everything we do. We recognize that for patients with rare and debilitating diseases, every day without an effective treatment is a day too late. We are driven by this urgency to evolve disease knowledge with an aim to develop novel precision medicines for severe and debilitating rare muscle disorders. We were incorporated in Delaware in May 2017. Our principal executive offices are located at 3415 Colorado Ave., Boulder, Colorado.

Data derived from most recent annual or quarterly report
Market Cap 822.675 Million Shares Outstanding49.262 Million Avg 30-day Volume 72.076 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 40.49 / 13.6 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million

View recent insider trading info

Funds Holding EWTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EWTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

120.3 Thousand total shares from 18 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RUSSELL ALAN J CHIEF SCIENTIFIC OFFICER

143,842 2021-10-14 7

KOCH KEVIN PRESIDENT AND CEO

400,000 2021-08-17 1

MOORE JOHN R GENERAL COUNSEL

120,000 2021-08-17 1

DONOVAN JOANNE M. CMO

160,000 2021-08-17 3

CARRUTHERS R MICHAEL CHIEF FINANCIAL OFFICER

120,000 2021-08-17 1

DERAKHSHAN BEHRAD CHIEF BUSINESS OFFICER

140,000 2021-08-17 1

FLYNN JAMES E

DEERFIELD MGMT IV, L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD PRIVATE DESIGN FUND IV, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2021-03-30 1

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VI LLC

ORBIMED GENESIS GP LLC

  • Director
  • 10% Owner
13,679,055 2021-03-30 1

ROOT JONATHAN D

  • Director
3,489,168 2021-03-30 1

THOMPSON PETER A.

  • Director
  • 10% Owner
13,679,055 2021-03-30 1

NOVO HOLDINGS A/S

  • 10% Owner
5,587,207 2021-03-30 1

WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) I L.P.

  • 10% Owner
No longer subject to file 2021-03-30 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

RUSSELL ALAN J CHIEF SCIENTIFIC OFFICER

2021-10-18 19:48:19 -0400 2021-10-15 S 126 $18.00 d 143,842 direct yes 5.7846 5.7846 2 0.0 1

RUSSELL ALAN J CHIEF SCIENTIFIC OFFICER

2021-10-18 19:48:19 -0400 2021-10-15 S 1,307 $18.13 d 143,968 direct yes 5.7846 5.7846 2 0.0 1

RUSSELL ALAN J CHIEF SCIENTIFIC OFFICER

2021-10-18 19:48:19 -0400 2021-10-14 S 5,749 $18.18 d 145,275 direct yes 5.7846 5.7846 2 0.0 1

RUSSELL ALAN J CHIEF SCIENTIFIC OFFICER

2021-10-13 18:51:12 -0400 2021-10-11 S 1,270 $18.02 d 151,024 direct yes -2.0431 -6.1292 0.0 1 -10.2706 4

RUSSELL ALAN J CHIEF SCIENTIFIC OFFICER

2021-10-08 18:00:35 -0400 2021-10-08 S 5,902 $18.15 d 152,294 direct 1.7647 2.1765 6.5294 4 0.0 1

RUSSELL ALAN J CHIEF SCIENTIFIC OFFICER

2021-10-08 18:00:35 -0400 2021-10-07 S 13,018 $18.56 d 158,196 direct 1.7647 2.1765 6.5294 4 0.0 1

RUSSELL ALAN J CHIEF SCIENTIFIC OFFICER

2021-10-08 18:00:35 -0400 2021-10-06 S 2,108 $18.03 d 171,214 direct yes 1.7647 2.1765 6.5294 4 0.0 1

RUSSELL ALAN J CHIEF SCIENTIFIC OFFICER

2021-10-05 18:33:47 -0400 2021-10-05 S 5,404 $18.26 d 173,322 direct 4.3046 -3.8631 4.3046 2 -6.181 4

RUSSELL ALAN J CHIEF SCIENTIFIC OFFICER

2021-10-05 18:33:47 -0400 2021-10-04 S 100 $18.00 d 178,726 direct 4.3046 -3.8631 4.3046 2 -6.181 4

RUSSELL ALAN J CHIEF SCIENTIFIC OFFICER

2021-10-05 18:33:47 -0400 2021-10-01 S 274 $18.00 d 178,826 direct 4.3046 -3.8631 4.3046 2 -6.181 4

RUSSELL ALAN J CHIEF SCIENTIFIC OFFICER

2021-09-30 19:16:11 -0400 2021-09-29 S 618 $17.47 d 179,100 direct 0.3991 4.333 7.7537 5 0.0 1

RUSSELL ALAN J CHIEF SCIENTIFIC OFFICER

2021-09-30 19:16:11 -0400 2021-09-29 S 11,226 $16.83 d 179,718 direct 0.3991 4.333 7.7537 5 0.0 1

RUSSELL ALAN J CHIEF SCIENTIFIC OFFICER

2021-09-30 19:16:11 -0400 2021-09-28 S 14,610 $17.30 d 190,944 direct yes 0.3991 4.333 7.7537 5 0.0 1

RUSSELL ALAN J CHIEF SCIENTIFIC OFFICER

2021-09-27 19:32:39 -0400 2021-09-27 S 17 $18.48 d 205,554 direct -2.0173 6.1671 6.1671 6 -4.3228 3

RUSSELL ALAN J CHIEF SCIENTIFIC OFFICER

2021-09-27 19:32:39 -0400 2021-09-27 S 11,594 $17.98 d 205,571 direct -2.0173 6.1671 6.1671 6 -4.3228 3

RUSSELL ALAN J CHIEF SCIENTIFIC OFFICER

2021-09-27 19:32:39 -0400 2021-09-24 S 20,100 $18.16 d 217,165 direct -2.0173 6.1671 6.1671 6 -4.3228 3

RUSSELL ALAN J CHIEF SCIENTIFIC OFFICER

2021-09-27 19:32:39 -0400 2021-09-23 S 21,763 $18.34 d 242,337 direct yes -2.0173 6.1671 6.1671 6 -4.3228 3

RUSSELL ALAN J CHIEF SCIENTIFIC OFFICER

2021-09-27 19:32:39 -0400 2021-09-23 S 5,072 $19.42 d 237,265 direct -2.0173 6.1671 6.1671 6 -4.3228 3

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
EDGEWISE THERAPEUTICS INC EWTX 2021-10-26 17:45:03 UTC -2.4094 2.4794 15000
EDGEWISE THERAPEUTICS INC EWTX 2021-10-26 17:15:03 UTC -2.4094 2.4794 15000
EDGEWISE THERAPEUTICS INC EWTX 2021-10-26 16:45:04 UTC -2.4094 2.4794 15000
EDGEWISE THERAPEUTICS INC EWTX 2021-10-26 16:15:03 UTC -2.4094 2.4794 15000
EDGEWISE THERAPEUTICS INC EWTX 2021-10-26 15:45:03 UTC -2.4094 2.4794 15000
EDGEWISE THERAPEUTICS INC EWTX 2021-10-26 15:15:03 UTC -2.4094 2.4794 15000
EDGEWISE THERAPEUTICS INC EWTX 2021-10-26 14:45:03 UTC -2.3991 2.4691 15000
EDGEWISE THERAPEUTICS INC EWTX 2021-10-26 14:15:05 UTC -2.3991 2.4691 15000
EDGEWISE THERAPEUTICS INC EWTX 2021-10-26 13:45:03 UTC -2.3991 2.4691 10000
EDGEWISE THERAPEUTICS INC EWTX 2021-10-26 13:15:03 UTC -2.3991 2.4691 10000
EDGEWISE THERAPEUTICS INC EWTX 2021-10-26 12:45:03 UTC -2.3991 2.4691 10000
EDGEWISE THERAPEUTICS INC EWTX 2021-10-25 22:15:03 UTC -2.3991 2.4691 10000
EDGEWISE THERAPEUTICS INC EWTX 2021-10-25 21:45:03 UTC -2.3991 2.4691 10000
EDGEWISE THERAPEUTICS INC EWTX 2021-10-25 21:15:03 UTC -2.3991 2.4691 10000
EDGEWISE THERAPEUTICS INC EWTX 2021-10-25 20:45:03 UTC -2.3991 2.4691 10000
EDGEWISE THERAPEUTICS INC EWTX 2021-10-25 20:15:03 UTC -2.3991 2.4691 10000
EDGEWISE THERAPEUTICS INC EWTX 2021-10-25 19:45:04 UTC -2.3991 2.4691 10000
EDGEWISE THERAPEUTICS INC EWTX 2021-10-25 19:15:03 UTC -2.3991 2.4691 10000
EDGEWISE THERAPEUTICS INC EWTX 2021-10-25 18:45:02 UTC -2.3991 2.4691 10000
EDGEWISE THERAPEUTICS INC EWTX 2021-10-25 18:15:03 UTC -2.3991 2.4691 10000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Weiss Strategic Interval Fund- Weiss Strategic Interval Fund EWTX -1455.0 shares, $-31035.15 2021-06-30 N-PORT
Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund EWTX -79.0 shares, $-1383.29 2021-07-31 N-PORT

Elevate your investments